# Pathios Therapeutics funding: rounds and investors

> Pathios Therapeutics has raised $34M across 2 rounds since 2019. Investors include Canaan, Brandon Capital and Innovate UK. Every round with its source.

Source: https://millionrounds.com/company/pathios-therapeutics (Millionrounds; every figure on the page links to its filing or article)

United Kingdom · [Series B startup](https://millionrounds.com/companies)

# Who invested in *Pathios Therapeutics*

2 rounds we have observed, with the 3 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech Healthcare

Funding summary Updated 26 Oct 2026

**$34M** raised across 2 rounds since 2019, from 2 sources

**$8.8M** Series A **$25M** Series B

- **Latest round:** Series B, $25M Apr 2024
- **Step-up i:** 2.8×
- **Investors:** 3

See who backed them

## The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2020 2021 2022 2023 2024

**$8.8M** Series A

**$25M** Series B

- **First round:** Series A, $8.8M
- **Biggest round:** $25M
- **Between rounds:** 4.3 years

## The rounds

- **Apr 2024** Series B **$25M** *1 new* *2 returning* [Innovate UK](https://millionrounds.com/fund/innovate-uk) [Canaan](https://millionrounds.com/fund/canaan-partners) [Brandon Capital](https://millionrounds.com/fund/brandon-capital) Source recorded
- **Dec 2019** Series A **$8.8M** *2 new* [Canaan](https://millionrounds.com/fund/canaan-partners) [Brandon Capital](https://millionrounds.com/fund/brandon-capital) Reported by FinSMEs

## Funding filed with regulators

Pathios Therapeutics filed one raise, $10.0M in all. Filings say how much was sold and to how many investors; they never name the investors.

- Feb 2024 **$10.0M** UK share allotment

## Founders and team

From Pathios Therapeutics's own website: 2 founders, 11 on the team.

**Stuart Hughes PhD** Co-Founder & MTM CEO

**Shelley Cook PhD** Executive Chair & Co-Founder

- **Ann Taylor-Hutchinson** Chief Executive Officer
- **Paul Higham** Chief Operating Officer
- **Barbara Cipriani PhD** Head of Clinical Operations
- **James Westcott PhD** Head of Corporate Governance & Business Operations Manager
- **Lisa Shoesmith** Head of People
- **Alan Naylor PhD** Senior Scientist
- **Alastair Corbin DPhil** Senior Scientist
- **Andrea Nisbet** Executive Assistant & Facilities Manager
- **Debbie Macaro** Director, Clinical Operations
- **Sam Harris** Director of Finance
- **Sean Carroll** Executive Assistant & Facilities Manager

Advisers *David Smith-Parkin* *Peter Joyce PhD*

## Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

**Series A** 2019 **Series B** 2024 [Canaan](https://millionrounds.com/fund/canaan-partners) [Brandon Capital](https://millionrounds.com/fund/brandon-capital) [Innovate UK](https://millionrounds.com/fund/innovate-uk)

## Everyone who backed them

[Canaan](https://millionrounds.com/fund/canaan-partners) VC firm **2** rounds

[Brandon Capital](https://millionrounds.com/fund/brandon-capital) VC firm **2** rounds

[Innovate UK](https://millionrounds.com/fund/innovate-uk) VC firm **1** round

Missing a round, or an investor who was in one? [Tell us](https://millionrounds.com/corrections?slug=pathios-therapeutics).

## Quick answers about Pathios Therapeutics

### Who invested in Pathios Therapeutics?

Pathios Therapeutics's investors include Canaan, Brandon Capital and Innovate UK.

### How much has Pathios Therapeutics raised?

Pathios Therapeutics has raised $34M across 2 rounds since 2019.

### When did Pathios Therapeutics last raise?

Pathios Therapeutics's most recent round was a Series B of $25M in Apr 2024.

### What was Pathios Therapeutics's biggest round?

Its most recent round, $25M in Apr 2024, is also its largest on record.

### Who backed Pathios Therapeutics first?

Pathios Therapeutics's first round on record, in Dec 2019, was backed by Canaan and Brandon Capital.

### What stage is Pathios Therapeutics at?

Pathios Therapeutics's latest named round is a Series B, in Apr 2024.

### Where is Pathios Therapeutics based?

Pathios Therapeutics is based in the United Kingdom.

## Companies like Pathios Therapeutics

In the same sector, and raised in the last eighteen months.

[**Coherence Neuro** $55M · Oct 2026](https://millionrounds.com/company/coherence-neuro)[**HydRegen** $12M · Oct 2026](https://millionrounds.com/company/hydregen)[**XRlabs** $8.4M · Oct 2026](https://millionrounds.com/company/xrlabs)[**OMass Therapeutics** $442M · Oct 2026](https://millionrounds.com/company/omass-therapeutics)[**CMR Surgical** $1.1B · Oct 2026](https://millionrounds.com/company/cmr-surgical)[**MintNeuro** $26M · Oct 2026](https://millionrounds.com/company/mintneuro)

## Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.

Open the investor searchOr these rounds in the app
